Skip to main content
. 2022 Mar 19;19(6):3677. doi: 10.3390/ijerph19063677

Figure 2.

Figure 2

Subjective measurements of maximum and relative explosive power of lower extremity muscles on post-test–placebo and post-test–LFCM. Values are mean (* = Significantly different (p < 0.05) from maximum explosive power week placebo, ** = Significantly different (p < 0.05) from relative explosive power week placebo, † = Significantly different (p < 0.05) from relative explosive power baseline, ‡ = Significantly different (p < 0.05) from maximum explosive power baseline).